Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadoxetate MRI in Hepatocellular Carcinoma
NCT02578602Phase 1Completed
- Sponsor
- University of Southern California
- Start
- Oct 2010
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of gadoxetate disodium in hepatocellular carcinoma (HCC), sponsored by University of Southern California. Primary endpoint: Precision in tumor measurement at 24 hours. Started Oct 2010; status: completed.
02
Drugs
gadoxetate disodium
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02578602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02578602.